Cabot Corporation Profile Avatar - Palmy Investing

Cabot Corporation

Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as…

Chemicals - Specialty
US, Boston [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 28% Weak
Profitability n.A. n.A.
Fin. Growth 50% Balanced
Leverage & Liquidity 33% Weak
Per Share Metrics 67% Positive
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q1 Q2 Δ in %
EV/EBITDA -12.47 31.70 36.21
Graham Fair Price 31.22 29.01 22.11
PEG -27.81 0.21 -0.29
Price/Book 8.21 3.76 3.47
Price/Cash Flow -57.32 38.64 90.54
Prices/Earnings -33.75 15.30 23.09
Price/Sales 4.64 5.04 4.82
Price/FCF -57.32 38.64 90.54
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q1 Q2 Δ in %
Gross Profit Margin 6.09 0.24 0.23
Operating Margin 7.84 0.15 0.14
ROA 72.63 0.02 0.01
ROE 0.04 0.06 63.33
ROIC 0.03 0.04 24.47
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q1 Q2 Δ in %
Debt QOQ -0.10 0.03 245.80
Dividends QOQ -0.04 0.04 -1.99
EBIT QOQ -0.04 0.15 248.04
EPS QOQ -0.79 0.73 -8.23
FCF QOQ -0.15 1.61 971.90
Revenue QOQ < 0.005 0.06 777.80
Naive Interpretation member
03 - Financial Growth · Balanced
Fundamentals

Leverage & Liquidity

Metric Q1 Q2 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 75.04 64.15 -14.51
Days Sales Outstanding (DSO) 68.20 65.71 -3.66
Inventory Turnover 1.20 1.40 16.97
Debt/Capitalization 0.50 0.46 -6.57
Quick Ratio 1.17 1.32 13.22
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q1 Q2 Δ in %
Book Value 24.03 24.68 2.67
Cash 4.41 3.72 -15.73
Capex -0.98 -0.78 20.51
Free Cash Flow 0.92 2.40 160.31
Revenue 17.32 18.39 6.18
Naive Interpretation member
05 - Per Share Metrics · Positive
Fundamentals

Financial Health

Metric Q1 Q2 Δ in %
Current Ratio 2.04 2.24 9.65
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 6.80 5.07 -25.51
Naive Interpretation Member
06 - Financial Health · Bad
End of CBT's Analysis
CIK: 16040 CUSIP: 127055101 ISIN: US1270551013 LEI: - UEI: -
Secondary Listings
CBT has no secondary listings inside our databases.